MacroGenics Provides Update on Corporate Progress and First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Macrogenics (MGNX) Extends Gain, Up 193%
May 6, 2020 12:49 PM EDTMacrogenics (NASDAQ: MGNX) Extends Gain, Up 193%
... MoreMacrogenics (MGNX) Tops Q1 EPS by 21c, Revenues Beat
May 5, 2020 5:23 PM EDTMacrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.81), $0.21 better than the analyst estimate of ($1.02). Revenue for the quarter came in at $13.68 million versus the consensus estimate of $9.54 million.
First Quarter 2020 Financial Results
Cash Position: Cash, cash equivalents and marketable securities as of March 31, 2020, were $170.8 million, compared to $215.8 million as of December 31, 2019. Revenue: Total revenue, consisting primarily of revenue from collaborative agreements, was $13.7 million for the quarter ended March 31, 2020, compared to $9.7 million for the quarter ended March 31, 2019. This increase was primarily due to revenue recognized for... More